Kling Biotherapeutics’ Post

“Educate. Advocate. Act Now” Kling Biotherapeutics is proud to support World AMR Awareness Week (#WAAW) from 18-24 November. Contributing to 5 million deaths every year, antimicrobial resistance (#AMR) is a global health crisis with many socioeconomic consequences. This worldwide campaign aims to raise awareness and understanding of AMR, alongside promoting best practices among the public, OneHealth stakeholders, and policymakers, to reduce the emergence and spread of drug-resistant infections. At #Kling, our clinically validated B cell immortalization technology has been successful in the discovery of the fully human Respiratory Syncytial Virus (RSV) neutralizing antibody #Nirsevimab that prevents RSV in infants and children under 24 months. By following an ‘effective antibody first’ discovery approach, Kling’s platform enables the discovery of relevant, completely novel antigen targets to help battle illnesses including cancer and #infectiousdiseases. AMR is invisible, but its victims are not! Let’s encourage one another to share our experiences of AMR and learn about its impact, to promote urgent global action. #WorldAMRAwarenessWeek #AntimicrobialResistance #drugdiscovery #drugdevelopment #Antimicrobial #AMRsurvivors

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics